# Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Study · id `cardio:ct-nct04097145` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04097145](<https://clinicaltrials.gov/study/NCT04097145>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04097145

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1270 participants.

## Technical summary

Registry record NCT04097145. Randomized; no masking; primary purpose treatment. Start 2019-12-11 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1270 participants (planned count; ClinicalTrials.gov record NCT04097145, source copy `cardio:ctgov-nct04097145-2026-11-16`, retrieved 2026-11-18)
- Started: 2019-12-11 (actual) (ClinicalTrials.gov record NCT04097145, source copy `cardio:ctgov-nct04097145-2026-11-16`, retrieved 2026-11-18)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT04097145, source copy `cardio:ctgov-nct04097145-2026-11-16`, retrieved 2026-11-18)
- Completion: 2031-12-31 (anticipated) (ClinicalTrials.gov record NCT04097145, source copy `cardio:ctgov-nct04097145-2026-11-16`, retrieved 2026-11-18)
- Countries: United States; Canada (ClinicalTrials.gov record NCT04097145, source copy `cardio:ctgov-nct04097145-2026-11-16`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04097145-2026-11-16`, retrieved 2026-11-18)

## The registry's words

- Brief title: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- Acronym: CLASP II TR
- Condition: Tricuspid Regurgitation
- Condition: Tricuspid Valve Insufficiency
- Condition: Tricuspid Valve Disease
- Intervention (Device): Edwards PASCAL System
- Intervention (Drug): Optimal Medical Therapy
- Intervention (Device): Edwards PASCAL System
- Intervention (Device): Edwards PASCAL System
- Lead sponsor: Edwards Lifesciences
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Tricuspid regurgitation (`cardio:tricuspid-regurgitation`)
- Registry lists this organization as the lead sponsor: Edwards Lifesciences (`cardio:edwards-lifesciences`)

## Provenance

Content hash: c6f651d6391211980cfa229d1059316be5ab58b911cec16584e76d9aa4f29f03
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
